CLINICAL EFFECTIVENESS OF HOME ECG MONITORING IN THE MANAGEMENT OF POST-INFARCTION CARDIAC ARRHYTHMIAS

Article Sidebar

PDF
Published: 2025-06-14
DOI: https://doi.org/10.55640/
Keywords:
Post-infarction monitoring, ventricular arrhythmia, ambulatory ECG, telemetric ECG, sudden cardiac death, myocardial infarction, home-based diagnostics, Holter monitoring comparison

Main Article Content

Hamroyeva Madinabonu Yo‘ldosh kizi
Bukhara State Medical Institute Assistant at the Department of Faculty and Hospital Therapy

Abstract

This study evaluates the clinical effectiveness of ambulatory telemetric electrocardiographic (AT ECG) monitoring in patients during the early post-myocardial infarction (MI) period. A total of 136 patients with Q-wave MI were divided into two comparable groups: 70 patients in the main group used AT ECG monitoring for 6 months, while 66 patients in the control group underwent standard follow-up by district cardiologists. All patients received comparable anti-ischemic and antiarrhythmic therapy. The frequency of ventricular arrhythmia detection was significantly higher in the AT ECG group due to more frequent and timely ECG recordings. The study demonstrated that the use of symptom-triggered and time-triggered ECG transmission modes allowed for the identification of both symptomatic and asymptomatic arrhythmias. Additionally, the dynamic ECG monitoring facilitated more frequent adjustments of pharmacological therapy, improving its individual optimization and safety. The results show that home-based AT ECG monitoring not only increases the detection rate of ventricular arrhythmias but also contributes to better therapeutic control and may reduce sudden cardiac death in post-MI patients.

Downloads

Download data is not yet available.

Article Details

Issue

Vol. 4 No. 5 (2025): Journal of Multidisciplinary Sciences and Innovations

Section

Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

How to Cite

CLINICAL EFFECTIVENESS OF HOME ECG MONITORING IN THE MANAGEMENT OF POST-INFARCTION CARDIAC ARRHYTHMIAS. (2025). Journal of Multidisciplinary Sciences and Innovations, 4(5), 499-502. https://doi.org/10.55640/

References

1.1.Hamroyeva M.Y., St. Elevation or Myocardium Infarction Shifohonagach Tizimli Thrombolysis Muammolari Va Ularning Echimi. Miasto Przyszłości. Vol. 49 (2024):420-431

2.2.Hamroyeva M.Y., St Segment Elevationali Otkir Coronar Sinromda Shifohonagacha Tisimli Thrombolysis Chap Korincha Systolic Dysfunctionsiga Ta'siri. Miasto Przyszłości. Vol. 49 (2024):376-381

3.3.Hamroyeva M.Y., Tug‘ma yurak nuqsonlarida o‘pka gipertenziyasi. Ilm fan xabarnomasi .Vol. 8 No. 1 (2025): 158-162

4.

5.4.Hamroyeva M.Y., Cardiac arrhythmias after myocardial infarction: Diagnostic approaches and therapeutic options. Iqro indexing. Vol. 16 No. 01 (2025): 153-160

6.5.Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984;69(2):250-8.

7.6.Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877-83.

8.7.Bauer A, Malik M, Schmidt G, Barthel P, Bonnemeier H, Cygankiewicz I, et al. Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use. Eur Heart J 2008;29(8):1186–1201.

9.8. Metting G, Kirchhof P, Andresen D, Meinertz T, Willems S. Ambulatory ECG monitoring – current status and future perspectives. Z Cardiol. 2004;93(7):529–538.

10.9.Olgin JE, Ziegler PD, Joy PS, et al. Remote monitoring of implantable cardioverter defibrillators: a prospective analysis. J Cardiovascular Electrophysiol. 2009;20(5):547–553.

11.10.Malik M, Camm AJ. Evaluation of drug-induced QT interval prolongation. Implications for drug approval and labeling. Drug Saf. 2001;24(5):323–351.

12.11.Barrett PM, Komatireddy R, Haaser S, et al. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med. 2014;127(1):95.e11-7.

13.12.Saxon LA. Remote monitoring of implantable cardioverter-defibrillators. Cardiol Clin. 2008;26(4):611–625.

14.13. Vardas PE, Auricchio A, Blanc JJ, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: the Task Force for cardiac pacing and resynchronization therapy of the European Society of Cardiology. Eur Heart J 2007;28(18):2256–2295.

15.14.Köhler B, Meinertz T, Götz A, et al. Telemetric home monitoring in cardiac patients: medical and economic benefits. Dtsch Med Wochenschr. 2003;128(40):2082–2087.

Similar Articles

You may also start an advanced similarity search for this article.